Thank you for your reply Geordie.
My initial thoughts when PVDM sold a minuscule portion of his holding a short time ago was to financially secure a, at the time, sort after new CEO, among other things and a stake in Biotome may not, in my opinion, have been beyond the realms of possibility. But as you have clarified with their latest SH list, is not the case.
BrainChip & Biotome - Govt Funding for neutralising antibodies SARS- CoV-2 infection, page-98
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $522.7M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 27.0¢ | 26.0¢ | $2.161M | 8.144M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 431626 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 399533 | 13 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| BRN (ASX) Chart |